Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC)

Stopped early · Phase 3

Conditions studied: Small Cell Lung Cancer

In brief

This project proposes to use bronchoscopic intratumoral chemotherapy for small cell lung cancer in two fashions: 1. to implement a prospective clinical trial to test the feasibility and efficacy of intralesional chemotherapy as consolidative therapy immediately following standard systemic chemotherapy and radiation therapy for patients with limited stage SCLC by comparing tumor growth and survival rates of the treatment group and compare the outcomes to historical controls 2. to implement a prospective clinical trial to test the feasibility and efficacy as measured by tumor growth and survival rates of intralesional chemotherapy for patients with recurrent SCLC after standard treatment.

Key facts

Study ID

NCT01487499

Run by

University of Florida

People needed

4

Starts

2011-12-01

Expected to finish

2015-03-01

Last updated by the study team

2015-06-11

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Subjects who do not meet the inclusion criteria
• Subjects who, in the opinion of the investigator, are at risk undergoing a bronchoscopy

Where it is running

• University of Florida — Gainesville, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.